BenzingaAugust 13, 2026 at 4:47 AM NY22 days ago

Candel Therapeutics Q2 EPS $(0.52) Misses $(0.23) Estimate

Candel Therapeutics (NASDAQ:CADL) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.23) by 126.09 percent. This is a 477.78 percent decrease over losses of $(0.09) per

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga

Read at Source

Companies in This Story

CADLCandel Therapeutics Inc12.78− 1.46%

Companies in This Story

Related Stories